Faeth in the News
The organization studies the effect that diet and precision nutrition has on cancerous tumors. Faeth’s model pairs standard cancer treatment with personalized meal plans for patients with different forms of the disease.
The San Francisco-based biotech is pairing metabolically-engineered diets with existing therapies to starve and kill tumors.
Cancer Research UK
Starving cancer cells of specific nutrients can slow tumour growth and sharpen the effects of chemotherapy and radiotherapy – now, startup Faeth Therapeutics is creating precision diets...
CTSI Discovery Radio
It’s a pancreatic cancer clinical trial incorporating a diet custom tailored to patients, hoping that targeted nutrition can starve cancer cells...
A new clinical trial is underway at the Medical College of Wisconsin. It takes a different approach to treat cancer and it all starts with what you eat.
Anand Parikh tells CBS42 their company was built to be the first of its kind in history, developing what they call the fourth pillar of cancer care- nutrition.
Famed oncologist Sid Mukherjee and repeat biotech co-founder Lew Cantley have teamed up to form Faeth Therapeutics....
KRTV Great Falls
Cancer is the second leading cause of death in the U.S., but researchers hope to improve that statistic through a new treatment undergoing human clinical trials right now.
Faeth Therapeutics announced a $47 million Series A funding round on Wednesday. The startup is studying specialized diets as a way to slow and...
Sunday Times UK
Sunday Times’ tech correspondent Danny Fortson brings on Anand Parikh, co-founder and chief executive of Faeth Therapeutics, to talk about using nutrition to treat cancer...
Faeth Therapeutics is a new cancer metabolism company developing clinically tested nutrition control, therapeutics, and digital tools for the treatment of cancer...
For all the advances oncology researchers have made in genomics and precision medicine, one of the most basic questions for cancer patients remains one of the least understood... What should I eat?
The Wall Street Journal
Interest among venture capitalists in the medical potential of food has risen as the understanding of diet’s role in disease has grown...